Lung preservation: from perfusion to temperature
暂无分享,去创建一个
[1] G. Verleden,et al. Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study. , 2022, The Journal of Heart and Lung Transplantation.
[2] S. Keshavjee,et al. Evaluation of 10°C as the optimal storage temperature for aspiration-injured donor lungs in a large animal transplant model. , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] R. Sade,et al. Normothermic Regional Perfusion: Ethical Issues in Thoracic Organ Donation. , 2022, The Annals of thoracic surgery.
[4] G. Snell,et al. Donation After Circulatory Death in lung transplantation. , 2022, Thoracic surgery clinics.
[5] B. Suberviola,et al. Lung transplantation from controlled donation after circulatory death using simultaneous abdominal normothermic regional perfusion: A single center experience , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] A. Zuckermann,et al. ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD). , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[7] S. Keshavjee,et al. Ex vivo lung perfusion , 2021, Journal of thoracic disease.
[8] A. Exadaktylos,et al. Brain–lung interactions and mechanical ventilation in patients with isolated brain injury , 2021, Critical Care.
[9] S. Knight,et al. A systematic review and meta‐analyses of regional perfusion in donation after circulatory death solid organ transplantation , 2021, Transplant international : official journal of the European Society for Organ Transplantation.
[10] L. Brochard,et al. Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function , 2021, Science Translational Medicine.
[11] N. Markin,et al. Successful lung transplantation with graft recovered after thoracoabdominal normothermic perfusion from donor after circulatory death , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] J. Klapper,et al. Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience. , 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] D. Paredes,et al. Consensus statement on normothermic regional perfusion in donation after circulatory death: Report from the European Society for Organ Transplantation’s Transplant Learning Journey , 2021, Transplant international : official journal of the European Society for Organ Transplantation.
[14] J. Copeland,et al. Donor heart and lung procurement: A consensus statement. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[15] J. Madsen,et al. Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. , 2019, The Lancet. Respiratory medicine.
[16] G. Meyfroidt,et al. Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality , 2019, Intensive Care Medicine.
[17] G. Snell,et al. Influence of lung donor agonal and warm ischemic times on early mortality: Analyses from the ISHLT DCD Lung Transplant Registry. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[18] F. Rea,et al. Pushing the limits of reconditioning: extended normothermic lung perfusion in an extended criteria donor. , 2018, Journal of Thoracic Disease.
[19] Marco Schiavon,et al. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. , 2018, The Lancet. Respiratory medicine.
[20] S. Keshavjee,et al. Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study. , 2017, The Lancet. Respiratory medicine.
[21] M. Erasmus,et al. DCD lung donation: donor criteria, procedural criteria, pulmonary graft function validation, and preservation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.
[22] J. Neuberger,et al. New classification of donation after circulatory death donors definitions and terminology , 2016, Transplant international : official journal of the European Society for Organ Transplantation.
[23] Stefan Fischer,et al. Retrograde in situ versus antegrade pulmonary preservation in clinical lung transplantation: a single-centre experience. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[24] Katharina M. Busl,et al. Neurogenic Pulmonary Edema , 2015, Critical care medicine.
[25] V. Valero,et al. Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation. , 2015, JAMA surgery.
[26] S. Keshavjee,et al. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[27] L. M. Anderson,et al. Innovative cold storage of donor organs using the Paragonix Sherpa Pak ™ devices , 2015, Heart, lung and vessels.
[28] B. Whitson,et al. Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature. , 2014, Journal of thoracic disease.
[29] S. Keshavjee,et al. Donor management and lung preservation for lung transplantation. , 2013, The Lancet. Respiratory medicine.
[30] Marcelo Cypel,et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. , 2011, The New England journal of medicine.
[31] G. Westall,et al. Effect of donor preservation solution and survival in lung transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[32] Arthur S Slutsky,et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. , 2010, JAMA.
[33] W. Baumgartner,et al. Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] G. Verleden,et al. Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion. , 2009, The Journal of surgical research.
[35] M. Zenati,et al. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. , 2008, The Annals of thoracic surgery.
[36] R. Stockley,et al. Early donor management increases the retrieval rate of lungs for transplantation. , 2008, The Annals of thoracic surgery.
[37] G. Snell,et al. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. , 2006, The Annals of thoracic surgery.
[38] G. Verleden,et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[39] P. Dartevelle,et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. , 2005, American journal of respiratory and critical care medicine.
[40] Stefan Fischer,et al. Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. , 2005, The Journal of thoracic and cardiovascular surgery.
[41] M. Ochs,et al. Innovative pulmonary preservation of non-heart-beating donor grafts in experimental lung transplantation. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[42] J. Hohlfeld,et al. Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. , 2002, The Journal of thoracic and cardiovascular surgery.
[43] Ming Liu,et al. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. , 2001, Transplantation.
[44] M. Sarsam. Preimplantation retrograde pneumoplegia in clinical lung transplantation. , 1999, The Journal of thoracic and cardiovascular surgery.
[45] Arthur S Slutsky,et al. Optimal inflation volume for hypothermic preservation of rat lungs. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[46] D. Follette,et al. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[47] R. Muraoka,et al. Relationship between flushing pressure and nitric oxide production in preserved lungs. , 1998, Transplantation.
[48] M. Oz,et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation. , 1996, Circulation research.
[49] M. Haniuda,et al. Effects of inflation volume during lung preservation on pulmonary capillary permeability. , 1996, The Journal of thoracic and cardiovascular surgery.
[50] R. Muraoka,et al. Influence of pulmonary arterial pressure during flushing on lung preservation. , 1996, Transplantation.
[51] G. Patterson,et al. Free radical-mediated vascular injury in lungs preserved at moderate hypothermia. , 1995, The Annals of thoracic surgery.
[52] F. Beyersdorf,et al. Distribution of lung preservation solutions in parenchyma and airways: influence of atelectasis and route of delivery. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[53] O. H. Lowry,et al. Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation. , 1993, The Journal of thoracic and cardiovascular surgery.
[54] J. Cooper,et al. In a canine model, lung preservation at 10° C is superior to that at 4° C: A comparison of two preservation temperatures on lung function and on adenosine triphosphate level measured by phosphorus 31-nuclear magnetic resonance , 1992 .
[55] Arthur S Slutsky,et al. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. , 1992, The Journal of thoracic and cardiovascular surgery.